NGM Biopharmaceuticals Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 158

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 10

NGM Biopharmaceuticals General Information

Description

Operator of a biopharmaceutical company intended to translate complex, powerful biology with rigor and urgency into life-changing medicines. The company is engaged in developing novel therapeutics based on a scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic, and ophthalmic diseases, providing clients with medicines to treat persistent diseases and improve the well-being of their patients.

Contact Information

Website
www.ngmbio.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 333 Oyster Point Boulevard
  • South San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Former Stock Listing
NGM
Corporate Office
  • 333 Oyster Point Boulevard
  • South San Francisco, CA 94080
  • United States
+1 (650)

NGM Biopharmaceuticals Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NGM Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NGM Biopharmaceuticals‘s full profile, request access.

Request a free trial

NGM Biopharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to translate complex, powerful biology with rigor and urgency into life
Drug Discovery
South San Francisco, CA
158 As of 2025

Boston, MA
 

West Conshohocken, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NGM Biopharmaceuticals Competitors (79)

One of NGM Biopharmaceuticals’s 79 competitors is Astria Therapeutics, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Astria Therapeutics Formerly VC-backed Boston, MA
Madrigal Pharmaceuticals Corporation West Conshohocken, PA
Iovance Biotherapeutics Corporation San Carlos, CA
Nimbus Therapeutics Venture Capital-Backed Boston, MA
NexImmune Formerly VC-backed Gaithersburg, MD
You’re viewing 5 of 79 competitors. Get the full list »

NGM Biopharmaceuticals Patents

NGM Biopharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023245607-A1 Ilt3 and cd3 binding agents and methods of use thereof Pending 29-Mar-2022
EP-4499683-A1 Ilt3 and cd3 binding agents and methods of use thereof Pending 29-Mar-2022
US-20230220076-A1 Combinational use of an anti-ilt3 antibody and an anti-lair-1 antibody Pending 21-Dec-2021
US-20230107304-A1 Methods of treating cancer and tumor-related weight loss and cachexia Inactive 10-Sep-2021
AU-2022266780-A9 Multimerization of binding molecules having an antibody constant region variant Pending 28-Apr-2021 C07K16/18
To view NGM Biopharmaceuticals’s complete patent history, request access »

NGM Biopharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NGM Biopharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NGM Biopharmaceuticals‘s full profile, request access.

Request a free trial

NGM Biopharmaceuticals FAQs

  • When was NGM Biopharmaceuticals founded?

    NGM Biopharmaceuticals was founded in 2008.

  • Where is NGM Biopharmaceuticals headquartered?

    NGM Biopharmaceuticals is headquartered in South San Francisco, CA.

  • What is the size of NGM Biopharmaceuticals?

    NGM Biopharmaceuticals has 158 total employees.

  • What industry is NGM Biopharmaceuticals in?

    NGM Biopharmaceuticals’s primary industry is Drug Discovery.

  • Is NGM Biopharmaceuticals a private or public company?

    NGM Biopharmaceuticals is a Private company.

  • What is NGM Biopharmaceuticals’s current revenue?

    The current revenue for NGM Biopharmaceuticals is .

  • How much funding has NGM Biopharmaceuticals raised over time?

    NGM Biopharmaceuticals has raised $122M.

  • Who are NGM Biopharmaceuticals’s investors?

    The Column Group has invested in NGM Biopharmaceuticals.

  • Who are NGM Biopharmaceuticals’s competitors?

    Astria Therapeutics, Madrigal Pharmaceuticals, Iovance Biotherapeutics, Nimbus Therapeutics, and NexImmune are some of the 79 competitors of NGM Biopharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »